These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21941156)

  • 1. Retrospective chart review of children with type 2 diabetes mellitus evaluating the efficacy of metformin vs. insulin vs. combination insulin/metformin.
    Meyer SL; Hoffman RP
    South Med J; 2011 Oct; 104(10):684-8. PubMed ID: 21941156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.
    Barnett AH; Dreyer M; Lange P; Serdarevic-Pehar M
    Diabetes Care; 2006 Jun; 29(6):1282-7. PubMed ID: 16732009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metformin glycinate on glycated hemoglobin A1C concentration and insulin sensitivity in drug-naive adult patients with type 2 diabetes mellitus.
    González-Ortiz M; Martínez-Abundis E; Robles-Cervantes JA; Ramos-Zavala MG; Barrera-Durán C; González-Canudas J
    Diabetes Technol Ther; 2012 Dec; 14(12):1140-4. PubMed ID: 22974412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of initiation of therapy with once-daily combination of a thiazolidinedione and a biguanide at an early stage of type 2 diabetes.
    Bell DS; Ovalle F
    Diabetes Obes Metab; 2004 Sep; 6(5):363-6. PubMed ID: 15287929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin.
    Blonde L; Wogen J; Kreilick C; Seymour AA
    Diabetes Obes Metab; 2003 Nov; 5(6):424-31. PubMed ID: 14617228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
    Rosenstock J; Rood J; Cobitz A; Biswas N; Chou H; Garber A
    Diabetes Obes Metab; 2006 Nov; 8(6):650-60. PubMed ID: 17026489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis.
    Phung OJ; Sobieraj DM; Engel SS; Rajpathak SN
    Diabetes Obes Metab; 2014 May; 16(5):410-7. PubMed ID: 24205921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to failure of oral therapy in children with type 2 diabetes: a single center retrospective chart review.
    Barnes NS; White PC; Hutchison MR
    Pediatr Diabetes; 2012 Nov; 13(7):578-82. PubMed ID: 22646303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.
    Malone JK; Bai S; Campaigne BN; Reviriego J; Augendre-Ferrante B
    Diabet Med; 2005 Apr; 22(4):374-81. PubMed ID: 15787659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.
    Meneghini LF; Traylor L; Schwartz SL
    Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.
    Rosenstock J; Sugimoto D; Strange P; Stewart JA; Soltes-Rak E; Dailey G
    Diabetes Care; 2006 Mar; 29(3):554-9. PubMed ID: 16505505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control.
    Rosenstock J; Rood J; Cobitz A; Huang C; Garber A
    Diabetes Obes Metab; 2006 Nov; 8(6):643-9. PubMed ID: 17026488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with type 2 diabetes: A randomized noninferiority trial.
    Gross JL; Nakano M; Colon-Vega G; Ortiz-Carasquillo R; Ferguson JA; Althouse S; Tobian JA; Berclaz PY; Milicevic Z
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S27-34. PubMed ID: 19772446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study.
    Blicklé JF; Hancu N; Piletic M; Profozic V; Shestakova M; Dain MP; Jacqueminet S; Grimaldi A
    Diabetes Obes Metab; 2009 Apr; 11(4):379-86. PubMed ID: 19087105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of hypoglycemic drugs in children with type 2 diabetes mellitus.
    Benavides S; Striet J; Germak J; Nahata MC
    Pharmacotherapy; 2005 Jun; 25(6):803-9. PubMed ID: 15927898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective chart review of uncontrolled use of metformin as an add-on therapy in type 2 diabetes.
    Johnson M; Krosnick A; Carson P; McDade AM; Laraway K
    Clin Ther; 1998; 20(4):691-8. PubMed ID: 9737829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant oral antihyperglycemic agent use and associated treatment outcomes after initiation of insulin therapy.
    Herman WH; Buse JB; Arakaki RF; Dungan KM; Jiang HH; Jacobson JG; Fahrbach JL
    Endocr Pract; 2011; 17(4):563-7. PubMed ID: 21550959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.